Kim M Kaiser

2.1k total citations
2 papers, 21 citations indexed

About

Kim M Kaiser is a scholar working on Infectious Diseases, Surgery and Oncology. According to data from OpenAlex, Kim M Kaiser has authored 2 papers receiving a total of 21 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Infectious Diseases, 1 paper in Surgery and 1 paper in Oncology. Recurrent topics in Kim M Kaiser's work include CAR-T cell therapy research (1 paper), IL-33, ST2, and ILC Pathways (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Kim M Kaiser is often cited by papers focused on CAR-T cell therapy research (1 paper), IL-33, ST2, and ILC Pathways (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Kim M Kaiser collaborates with scholars based in Germany, Australia and United States. Kim M Kaiser's co-authors include Susanne V. Schmidt, Benjamin Krämer, Alexandru Odainic, Jenny Bischoff, Malte B. Monin, Jan Raabe, Jacob Nattermann, Eicke Latz, Kathrin van Bremen and Gereon Rieke and has published in prestigious journals such as Hepatology and The Journal of Infectious Diseases.

In The Last Decade

Kim M Kaiser

2 papers receiving 21 citations

Peers

Kim M Kaiser
Jan Raabe Germany
Kim M Kaiser
Citations per year, relative to Kim M Kaiser Kim M Kaiser (= 1×) peers Jan Raabe

Countries citing papers authored by Kim M Kaiser

Since Specialization
Citations

This map shows the geographic impact of Kim M Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim M Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim M Kaiser more than expected).

Fields of papers citing papers by Kim M Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim M Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim M Kaiser. The network helps show where Kim M Kaiser may publish in the future.

Co-authorship network of co-authors of Kim M Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Kim M Kaiser. A scholar is included among the top collaborators of Kim M Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim M Kaiser. Kim M Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Raabe, Jan, Kim M Kaiser, Michael ToVinh, et al.. (2023). Identification and characterization of a hepatic IL-13–producing ILC3-like population potentially involved in liver fibrosis. Hepatology. 78(3). 787–802. 9 indexed citations
2.
Rieke, Gereon, Kathrin van Bremen, Jenny Bischoff, et al.. (2022). Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination. The Journal of Infectious Diseases. 225(10). 1688–1693. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026